Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo

scientific article published on 04 February 2020

Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TAAP.2020.114913
P698PubMed publication ID32032644

P50authorChandraiah GoduguQ84125640
P2093author name stringSwarna Bale
Gauthami Pulivendala
P921main subjectpulmonary fibrosisQ32446
P304page(s)114913
P577publication date2020-02-04
P1433published inToxicology and Applied PharmacologyQ2446974
P1476titleHonokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo
P478volume391

Search more.